Home Cart Sign in  
Chemical Structure| 1629229-37-3 Chemical Structure| 1629229-37-3

Structure of Fezolinetant
CAS No.: 1629229-37-3

Chemical Structure| 1629229-37-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fezolinetant is Neurokinin-3 (NK-3) receptor antagonist.

Synonyms: ESN-364

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Fezolinetant

CAS No. :1629229-37-3
Formula : C16H15FN6OS
M.W : 358.39
SMILES Code : O=C(C1=CC=C(F)C=C1)N2[C@H](C)C3=NN=C(C4=NC(C)=NS4)N3CC2
Synonyms :
ESN-364
MDL No. :MFCD30532641
InChI Key :PPSNFPASKFYPMN-SECBINFHSA-N
Pubchem ID :117604931

Safety of Fezolinetant

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04641260 Healthy Subjects PHASE1 COMPLETED 2021-02-21 Parexel, Baltimore, Maryland, ... More >>21225, United States Less <<
NCT04451226 Hot Flashes PHASE3 COMPLETED 2022-06-13 Site CN86002, Beijing, China|S... More >>ite CN86015, Beijing, China|Site CN86029, Beijing, China|Site CN86032, Chengdu, China|Site CN86001, Guangzhou, China|Site CN86019, Guangzhou, China|Site CN86022, Guangzhou, China|Site CN86040, Guangzhou, China|Site CN86042, Guangzhou, China|Site CN86008, Hangzhou, China|Site CN86012, Hangzhou, China|Site CN86005, Hunan, China|Site CN86039, Jiangsu, China|Site CN86010, Jinlin, China|Site CN86020, Kunming, China|Site CN86037, Liuzhou, China|Site CN86006, Nanjing, China|Site CN86007, Nanjing, China|Site CN86018, Nanning, China|Site CN86034, Ningxia Hui Nationality Autonomous Region, China|Site CN86009, Shanghai, China|Site CN86011, Shanxi, China|Site CN86004, Shenzhen, China|Site CN86028, Shijiazhuang, China|Site CN86026, Suzhou, China|Site CN86038, Taiyuan, China|Site CN86030, Tianjin, China|Site CN86036, Tianjin, China|Site CN86025, Wuhan, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.79mL

0.56mL

0.28mL

13.95mL

2.79mL

1.40mL

27.90mL

5.58mL

2.79mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories